Clinical Trials Browser

Phase 4 × Palonosetron × Clear all

NCT05841849 2023-05-03

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms, Vomiting

NCT02532634 2018-05-11

RAPA

Phase 4 Completed

Neoplasms, Vomiting

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT01481831 2012-12-31

ESPNV

Phase 4 Completed

Neoplasms, Vomiting

NCT00415103 2009-09-18

AMENO-2

Phase 4 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting